Search

Search form

Joseph Lazzarotti Discusses Implications of New Digital Tracking Pill Approved by FDA

Joseph Lazzarotti Discusses Implications of New Digital Tracking Pill Approved by FDA

Joseph Lazzarotti discusses data security and patient consent concerns surrounding the first FDA approved digital pill in "New digital pill raises consent, data security issues," published by BenefitsPRO.com.

Subscription may be required to view article

People